期刊文献+

儿童淋巴瘤诊治进展——第57届美国血液会议(ASH)淋巴瘤部分的介绍 被引量:3

下载PDF
导出
摘要 第57届美国血液会议(ASH)于2015年12月5日-8日在美国佛罗里达州奥兰多召开,其中儿科继续教育部分涉及淋巴瘤专业有两个专题:儿童及青少年非霍奇金淋巴瘤(non-Hodgkin lymphoma,NHL)的靶向治疗进展及如何提高霍奇金淋巴瘤(HL)的治疗指数。
出处 《中国小儿血液与肿瘤杂志》 CAS 2016年第2期110-112,F0003,共4页 Journal of China Pediatric Blood and Cancer
基金 北京市医院管理局临床医学发展专项(项目编号:ZY201404)
  • 相关文献

参考文献7

  • 1Pro B,Advani R,Brice P,et al.Brentuximab vedotin(SGN-35)in patients with relapsed or refractory systemic anaplastic large-cell lymphoma;results of a phase II study.J Clin Oncol,2012,30:2190-2196.
  • 2Goldman S,Smith L,Galardy P,et al.Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia:a Children's Oncology Group Report.Br J Haematol,2014,167:394-401.
  • 3Meinhardt A,Burkhardt B,Zimmerinann M,et al.PhaseⅡwindow study on rituximab in newly diagnosed pediatric mature B-cell nonHodgkin's lymphoma and Burkitt leukemia.J Clin Oncol,2010,28:3115-3121.
  • 4Maude SL.Frey N,Shaw PA,et al.Chimeric antigen receptor T cells for sustained remissions in leukemia.N Engl J Med,2014,371:1507-1517.
  • 5Keller FG,Nachman J,Constine L,et al.A phase III study for the treatment of children and adolescents with newly diagnosed low risk Hodgkin lymphoma(HL)Blood,2010,116:337.
  • 6Cozen W,Timofeeva MN,Li D,et al.A meta-analysis of Hodgkin lymphoma reveals 19pl3.3 TCF3 as a novel susceptibility locus.Nat Commun,2014,5:3856.
  • 7Best T,Li D,Skol A,et al.Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma.Nat Med,2011,17:941-943.

同被引文献29

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部